$LFER Life On Earth, Inc. Closes Acquisition of “The

New Post Public Reply Private Reply Replies (0) Message Board
louied91
544
$LFER Life On Earth, Inc. Closes Acquisition of “The Giant Beverage Company, Inc.”

https://www.otcmarkets.com/stock/LFER/news/Li...?id=190648

NEW YORK, April 30, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--Life On Earth, Inc. (OTCQB:LFER) (the “Company” or “Life on Earth”), a brand accelerator company in the healthier and functional beverage and snack industry announced today that it has closed the acquisition of The Giant Beverage Company, Inc. (Giant). The Company expects the acquisition to increase its revenues by over 100% on an annual basis and be EBITDA accretive within a quarter thereafter. Life On Earth’s portfolio in the alternative and functional beverage category will now benefit from the Company’s own Direct Store Delivery (“DSD”) systems in California (Northern CA) and New York (New York City and Metropolitan Region).

“This acquisition marks a significant milestone in our Company’s history and it’s the third acquisition we have closed in the past 18 months," said Chairman and Chief Executive Officer, Mr. Fernando Oswaldo Leonzo. “During this period, we have grown from $200,000 in annual revenues to over $7 Million with plans for meaningful organic growth, as we consolidate overlapping infrastructure, add additional brands and leverage each brands’ already established relationships. As with our previous acquisitions, this transaction further supports our strategic initiative by adding scale in key markets by introducing new capabilities while enhancing our ability to grow our proprietary business with new and existing clients. We are confident that we have the right people, products and infrastructure to drive meaningful top and bottom line growth, as we strive to position the company for an up-listing, to a primary exchange, in our next fiscal year (‘19) which begins on June 1st 2018,” he continued.

“On an operational level, we can now receive shipments of our Victoria’s Kitchen brand and its related SKUs, that we have been developing,” said John Romagosa, Life On Earth’s President. “We are also expanding distribution of our GRAN NEVADAÔ products in New York City, as we improve our current portfolio with better quality and healthier alternatives, including our exclusive brands such as Hemp2OÔ and other potential brand acquisitions. Our industries’ best seasons for forward growth are upon us and we are now strategically positioned to expand revenue and cash flow. The timing of these recent transactions is optimal, allowing for Life On Earth to double (or triple) the size and scale of our operations,” he continued.

The Company has filed a Form 8-K with the US Securities Exchange Commission (“SEC”) in conjunction with this press release and readers can view the full filing on the SEC website or the Company’s Investor Relations section of LFER’s website. Visit: www.lifeonearthinc.com

About Life On Earth, Inc.

Life on Earth, Inc. (“Life on Earth” or the “Company”), a "Naturally Better Way" consumer-based and brand accelerator is a dynamic and innovative all-natural consumables products company focused, but not limited to the beverage and snack industry. The Company has established a unique business model focused on building brands within the alternative beverage and snack space. The Company’s brand model is complimented by its strong distribution subsidiaries Energy Source Distributors, Inc. (“ESD”) in California and The Giant Beverage Company, Inc. (“Giant”) in the New York City Metropolitan area. The growth of “game changing” marketing applications, human capital resources and follow-on investments will help Life on Earth deliver a fully integrated platform for the emerging and functional brand category that are good for its consumers as well as the environment.

Visit: www.lifeonearthinc.com

SAFE HARBOR ACT

Forward-Looking Statements: This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Life on Earth, Inc. (“Life on Earth” or the “Company”) its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements including those relating to the Company’s financing being adequate for the Company to close this acquisition, being able to place its products in the retail stores, to launch its growth and expansion plans among others, are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Life on Earth’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. No information in this press release should be construed in any way whatsoever as an indication of Life on Earth’s future revenues, financial performance or stock price. More information about the potential factors that could affect the business and financial results is and will be included in Life on Earth’s filings with the Securities and Exchange Commission at www.sec.gov.


Investors and Corporate Relations

Please Contact: info@lifeonearthinc.com

(516) 867- 8383

Life on Earth Inc (LFER) Stock Research Links

LFER Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 60

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 637

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 107

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 21

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 208

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 251

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 49

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 224

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading

Top 5 Most Recently Viewed Articles

Leadership Transition at Ignitis Renewables Sparks Future Growth

Updated Category News Views 134

Leadership Transition at Ignitis Renewables AB “Ignitis grup?” has announced a significant change in leadership with the resignation of Thierry Aelens, the Chief Executive Officer (CEO) of its subsidiary, UAB “Ignitis Renewables.” Aelens will step down effective at the end of March 2025 for personal reasons and to pursue new career opportunities nearer to his...

Continue Reading
Katalyze AI Elevates Innovation with New Chief AI Officer

Updated Category News Views 206

Advancing Pharmaceutical Manufacturing with AI Leadership Katalyze AI has recently announced a pivotal move to strengthen its capabilities in the fast-evolving field of pharmaceutical manufacturing. The company has appointed Hannes Bretschneider as Chief AI Officer, signaling its commitment to advancing Agentic AI architecture. This strategic initiative aims to enhance...

Continue Reading
Iran's Strait Closure: Defense Stocks on Edge Amid Shipping Risks

Updated Category News Views 325

Iran announced the temporary closure of the Strait of Hormuz for live-fire drills, raising eyebrows across trading desks. This isn't just a geopolitical stunt; it’s a shot across the bow at U. S. military presence in the region, occurring right as indirect nuclear talks unfold with Washington. A maneuver like this sends ripples through markets that thrive on stability,...

Continue Reading
Aphaia Pharma's Engagement in Revolutionary Obesity Forum

Updated Category News Views 117

Aphaia Pharma's Engagement in Revolutionary Obesity Forum Aphaia Pharma, a leading clinical-stage biopharmaceutical company, is making waves in the field of treatments for obesity and related metabolic disorders. The company has announced that its Chief Scientific Officer, Dr. Steffen-Sebastian Bolz, will share insights during a panel discussion at the much-anticipated...

Continue Reading
U.S. Strives to Diminish China's Dominance in Rare Earths

Updated Category News Views 216

Understanding the Importance of Rare Earth Elements In recent discussions, the significance of rare earth elements (REEs) has come to the forefront of international policy. These elements play a crucial role in various sectors, from technology to defense. Currently, China holds a dominant position in the production and refinement of these vital minerals, controlling...

Continue Reading